D.E. Shaw & Co
EOLS icon

D.E. Shaw & Co’s Evolus EOLS Stock Holding History

D.E. Shaw & Co’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-50,000
Closed -$595K – 3678
2018
Q4 		$595K Buy
+50,000
New +$713K ﹤0.01% 2996

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's EOLS Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Evolus (EOLS) stake by 64% in Q1 2026, selling an estimated $4.76M and leaving 559,050 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2816.

D.E. Shaw & Co first reported a position in EOLS in Q3 2018 and has held it in 22 quarters since. The position peaked at $15.7M in Q3 2024. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • D.E. Shaw & Co held 559,050 shares of Evolus worth $2.3M as of Q1 2026.
  • D.E. Shaw & Co sold 982,046 Evolus shares in Q1 2026, an estimated $4.76M.
  • Evolus made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2816 holding.
  • D.E. Shaw & Co first reported a position in Evolus in Q3 2018 and has held it in 22 quarters since.
  • D.E. Shaw & Co's Evolus position peaked at $15.7M in Q3 2024.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.